EHMT2 and gastric cancer: The efficacy of EHMT2 inhibition was further confirmed in a 3D spheroid culture system, PDOs, and a xenograft model.<h4>Conclusions</h4>Our findings suggest that EHMT2 is an attractive therapeutic target for GC treatment.